📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
SUVEN LIFE SCIENCES LTD.SUVENHealthcare Research- Analytics & Technology
Open
137.87
High
138.69
Low
132.11
Close
134.07
Volume
248500
Exchange
nse
Time
23-Jan-2026

Outlook

Score:

0

Rating:

RISKY

Candlestick Pattern

CandlepatternofSuvenLifeSciencesis
None
EstimatedStoplossofSuvenLifeSciencesis
138.69
SuvenLifeScienceshasa
Bearishℹ
pattern.
Formationof
None
candlepatternindicatesthetrenddirectionofSuvenLifeSciencesis
Unpredictableℹ
.

Trend

SuvenLifeSciencesisin
Downtrendℹ
.
PriceofSuvenLifeSciencesis
Downℹ
by

17.99

%.
Target
Buy@

133.25

Sell@

176

Current@

134.07

Volume

SuvenLifeScienceshasseen
Moderateℹ
volumeoftrades.
ThevolumetrendforSuvenLifeSciencesis
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofSuvenLifeSciencesis

Up

by

13.41

%

Valuation

ThecurrentmarketpriceofSuvenLifeSciencesis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth135crandtotalassetsworth135cr,thebalancesheetofSuvenLifeSciencesis:
Balancedℹ
.
Cashflow
SuvenLifeScienceshas
Insufficientℹ
cashflowbecauseitis

₹ 0cr

.Itis
Upℹ
by

100

%.
50% i.e. ₹ 154cr spent in operatingℹ
50% i.e. ₹ 154cr earned in investingℹ
0% in financingℹ
0% in otherℹ
SuvenLifeScienceshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 22cr

.Itis
Downℹ
by

170.97

%.
54.76% i.e. ₹ 115cr spent in operatingℹ
44.76% i.e. ₹ 94cr earned in investingℹ
0.48% i.e. ₹ 1cr spent in financingℹ
0% in otherℹ
Income
TheincomeofSuvenLifeSciencesis

₹ 4cr

and

Loss

is:

₹ 77cr

SuvenLifeSciencesLossesincreasedby:

50.98

%andIncomeisUpby:

100

%
TheincomeofSuvenLifeSciencesis

₹ 2cr

and

Loss

is:

₹ 51cr

SuvenLifeSciencesLossesincreasedby:

18.6

%andIncomeisUpby:

0

%
TheincomeofSuvenLifeSciencesis

₹ 2cr

and

Loss

is:

₹ 43cr

SuvenLifeSciencesLossesincreasedby:

10.26

%andIncomeisDownby:

33.33

%
By using this site you agree to the use of cookies to deliver a better site experience.